Skip to main content

Global Newsroom

CSL Behring Patient Zahra Khan, living with hereditary angioedema

Global Newsroom

Recent News Releases

Featuring releases from CSL, CSL Behring, CSL Seqirus and CSL Vifor.

Oct 24, 2024

MELBOURNE – 24 October 2024 – Two scientists have each been awarded CSL Centenary Fellowships, valued at $1.25 million over five years. They are developing...

Read more news from CSL

Recent News Releases
Jan 16, 2024

Findings show that convenience of treatment and flexibility of administration, such as at-home treatment options, are of high importance to patients KING OF PRUSSIA, Pa., Jan. 16, 2024...

Read more news from CSL Behring

Recent News Releases
Sep 26, 2024

As we approach the OPTIONS XII for the Control of Influenza, a global scientific meeting that focuses on influenza, there is an enormous sense of pride among all of us at CSL Seqirus. For the...

Read more news from CSL Seqirus

Recent News Releases
Oct 17, 2024

Temporary marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024...

Read more news from CSL Vifor

Read all company news releases

Media Resources

Media Contacts

CSL 
Victoria, Australia
Phone: +61 450 909 211
Email: media@csl.com.au

CSL Behring
North America
Email: MediaNorthAmerica@cslbehring.com

Europe
Email: MediaEurope@cslbehring.com

Asia Pacific
Email: MediaAsiaPacific@cslbehring.com

CSL Seqirus
UK, EMA, Argentina
Olga Scott
Phone: +44 (0) 777 167 3910
Email: Olga.Scott@seqirus.com

North America
Tiffany Cody
Phone: +1 908 370 1863
Email: Tiffany.Cody@seqirus.com

Asia Pacific
Hamish Walsh
Phone: +61 422 424 338
Email: Hamish.Walsh@seqirus.com

Global Commercial Development
Emmanuella Dekonor
Phone: +44 7920500496
Email: Emmanuella.Dekonor@seqirus.com

CSL Vifor
Switzerland
media@viforpharma.com

CSL Plasma
United States
Plasma.Communications@CSLPLASMA.COM

Follow Us Online
  • linkedin icon
  • twitter icon
  • youtube icon
  • facebook icon
  • instagram icon
Get our latest news releases in your inbox
* Required Fields